Skip to content

An observational study evaluating prevalence of frailty in patients with urological disease (FRAURO study)

An observational study evaluating prevalence of frailty in patients with urological disease (FRAURO study) - An observational study evaluating prevalence of frailty in patients with urological disease (FRAURO study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025057
Enrollment
1000
Registered
2017-01-31
Start date
2013-08-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological diseases

Interventions

None listed

Sponsors

Dept. of Urology, Hirosaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Males and females, 20 years or older, with urological disease who visit Hirosaki University Hospital.

Exclusion criteria

Exclusion criteria: Have any condition, limitation, or disease that could, in the judgment of the investigator, preclude evaluation of questionnaire or frail measurements.

Design outcomes

Primary

MeasureTime frame
Detection of frailty among the patients with urological cancers and develop a Comprehensive Geriatric Assessment (CGA) tool.

Secondary

MeasureTime frame
The clinical implication of frailty on outcomes including treatment outcomes. The effect of this biological-expected life age discrepancy on overall survival was retrospectively evaluated using patients in the previous study.

Countries

Japan

Contacts

Public ContactShingo Hatakeyama

Hirosaki University Hospital Dept. of Urology

shingoh@hirosaki-u.ac.jp0172-39-5091

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026